Literature DB >> 28813897

Design and testing of an under-actuated surface EMG-driven hand exoskeleton.

A Lince, N Celadon, A Battezzato, A Favetto, S Appendino, P Ariano, M Paleari.   

Abstract

Stroke and other neurological pathologies are an increasing cause of hand impairment, involving expensive rehabilitative therapies. In this scenario, robotics applied to hand rehabilitation and assistance appears particularly promising in order to lower therapy costs and boost its efficacy. This work shows a recently conceived hand exoskeleton, from the design and realization to its preliminary evaluation. A control strategy based on surface electromyography (sEMG) signals is integrated: preliminary tests performed on healthy subjects show the validity of this choice. The testing protocol, applied on healthy subjects, demonstrated the robustness of the whole system, both in terms of mimicking a physiological distribution of finger forces across subjects, and of realizing an effective control strategy based on the user's intention.

Entities:  

Mesh:

Year:  2017        PMID: 28813897     DOI: 10.1109/ICORR.2017.8009325

Source DB:  PubMed          Journal:  IEEE Int Conf Rehabil Robot        ISSN: 1945-7898


  3 in total

1.  Assisting Forearm Function in Children With Movement Disorders via A Soft Wearable Robot With Equilibrium-Point Control.

Authors:  Jonathan Realmuto; Terence D Sanger
Journal:  Front Robot AI       Date:  2022-06-15

Review 2.  Intention Detection Strategies for Robotic Upper-Limb Orthoses: A Scoping Review Considering Usability, Daily Life Application, and User Evaluation.

Authors:  Jessica Gantenbein; Jan Dittli; Jan Thomas Meyer; Roger Gassert; Olivier Lambercy
Journal:  Front Neurorobot       Date:  2022-02-21       Impact factor: 2.650

3.  Development of an EMG-Controlled Knee Exoskeleton to Assist Home Rehabilitation in a Game Context.

Authors:  Mingxing Lyu; Wei-Hai Chen; Xilun Ding; Jianhua Wang; Zhongcai Pei; Baochang Zhang
Journal:  Front Neurorobot       Date:  2019-08-27       Impact factor: 2.650

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.